Usefulness of hyperbaric oxygen therapy to inhibit restenosis after percutaneous coronary intervention for acute myocardial infarction or unstable angina pectoris.
The purpose of this trial was to assess whether the addition of hyperbaric oxygen to percutaneous coronary intervention can reduce clinical restenosis. Major adverse cardiac events at 8 months were found in only 1 of 24 patients (4%) who received hyperbaric oxygen compared with 13 of 37 patients (35%) who did not.
Sharifi
Mohsen
M
Department of Cardiology, St. Vincent Charity Hospital, Case Western Reserve University and the University Hospital of Cleveland, Ohio, USA. mohsen.sharifi@ttuhsc.edu
Fares
Wassim
W
Abdel-Karim
Isam
I
Koch
J Michael
JM
Sopko
Joseph
J
Adler
Dale
D
D000368:Aged; D000789:Angina, Unstable / Q000628:therapy*; D015906:Angioplasty, Balloon, Coronary; D017023:Coronary Angiography; D023903:Coronary Restenosis / Q000517:prevention & control*; D005260:Female; D006801:Humans; D006931:Hyperbaric Oxygenation; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000628:therapy*; D016896:Treatment Outcome